Research
-
Отчет о “вечнозеленых” патентах в Украине
В исследовании проанализировано 132 патента на наиболее жизненно важные лекарственные средства в Украине на предмет того, относятся ли они к категории...
-
Evergreening patents in Ukraine
The research analyzes 132 patents for the most important life-saving medicines in Ukraine on whether they can be considered as...
-
TRIPS-plus analysis Ukraine
A report on the legal analysis of TRIPS-plus provisions in Ukraine. A look at the legal framework and opportunities for...
-
Analysis of Ukraine’s single-source drug market
Report on the analysis of the single-source drugs market in Ukraine. A useful tool for treatment activists, and which can...
-
Анализ закупок АРВ-препаратов в Российской Федерации в 2019 году
Коалиция по готовности к лечению
-
Analysis: ARV procurement, Russia 2019
ITPC-ru’s 10th year of community-monitoring and analysis in the Russian Federation.
-
Campaign toolkit – our complete guide
Our toolkit will guide you through all the steps to challenge intellectual property barriers, from the life-cycle of a patent,...
-
Minimum costs to manufacture new treatments for COVID-19
‘Repurposing’ existing drugs to treat COVID-19 is vital to reducing mortality and controlling the pandemic. Researchers from the University of...
-
The problem with patents
This joint policy brief outlines how patents, and their effect on the cost of HIV treatment, threatens to undermine the HIV response in middle-income countries.
-
Access to Hep C treatment among people who inject drugs
A publication produced by Treatment Action Group (TAG) and Médecins du Monde.
-
Global Survey on Access to and Quality of HIV Treatment and Care
The 2019 survey focused on barriers to quality HIV care and treatment across 14 low- and middle-income countries covering seven...
-
Activist guide to Hepatitis C diagnostics
Produced by the Treatment Action Group (TAG), the Activist Guide outlines major barriers to accessing testing technologies and services.
